{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:37:21Z","timestamp":1768685841592,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Futuro in Ricerca 2012","award":["RBFR12SOQ1_001"],"award-info":[{"award-number":["RBFR12SOQ1_001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s00210-016-1266-y","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T16:04:04Z","timestamp":1467129844000},"page":"1033-1043","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents"],"prefix":"10.1007","volume":"389","author":[{"given":"F.","family":"Fusi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Durante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Spiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Trezza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Frosini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Floriddia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Teodori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Saponara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,28]]},"reference":[{"key":"1266_CR1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/jcb.25302","volume":"117","author":"C Brizi","year":"2016","unstructured":"Brizi C, Santulli C, Micucci M, Budriesi R, Chiarini A, Aldinucci C, Frosini M (2016) Neuroprotective effects of Castanea sativa Mill. bark extract in human neuroblastoma cells subjected to oxidative stress. J Cell Biochem 117:510\u2013520","journal-title":"J Cell Biochem"},{"key":"1266_CR2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","volume":"42","author":"R Callaghan","year":"2014","unstructured":"Callaghan R, Luk F, Bebawy M (2014) Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy? Drug Metab Dispos 42:623\u2013631","journal-title":"Drug Metab Dispos"},{"key":"1266_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","volume":"370","author":"Z Chen","year":"2016","unstructured":"Chen Z, Shi T, Zhang L, Deng M, Huang C, Hu T, Jiang L, Li J (2016) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett 370:153\u2013164","journal-title":"Cancer Lett"},{"key":"1266_CR4","doi-asserted-by":"crossref","first-page":"28332","DOI":"10.1074\/jbc.M109.027326","volume":"284","author":"RC Cheng","year":"2009","unstructured":"Cheng RC, Tikhonov DB, Zhorov BS (2009) Structural model for phenylalkylamine binding to L-type calcium channels. J Biol Chem 284:28332\u201328342","journal-title":"J Biol Chem"},{"key":"1266_CR5","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1021\/jm0491851","volume":"48","author":"G Cianchetta","year":"2005","unstructured":"Cianchetta G, Singleton RW, Zhang M, Wildgoose M, Giesing D, Fravolini A, Cruciani G, Vaz RJ (2005) A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR. J Med Chem 48:2927\u20132935","journal-title":"J Med Chem"},{"key":"1266_CR6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejmech.2014.09.084","volume":"87","author":"S Dei","year":"2014","unstructured":"Dei S, Coronnello M, Floriddia E, Bartolucci G, Bellucci C, Guandalini L, Manetti D, Romanelli MN, Salerno M, Bello I, Mini E, Teodori E (2014) Multidrug resistance (MDR) reversers: high activity and efficacy in a series of asymmetrical N,N-bis(alkanol) amine aryl esters. Eur J Med Chem 87:398\u2013412","journal-title":"Eur J Med Chem"},{"key":"1266_CR7","doi-asserted-by":"crossref","first-page":"e0121634","DOI":"10.1371\/journal.pone.0121634","volume":"10","author":"P Fransen","year":"2015","unstructured":"Fransen P, Van Hove CE, Leloup AJ, Martinet W, De Meyer GR, Lemmens K, Bult H, Schrijvers DM (2015) Dissecting out the complex Ca2+-mediated phenylephrine-induced contractions of mouse aortic segments. PLoS One 10:e0121634","journal-title":"PLoS One"},{"key":"1266_CR8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00210-003-0836-y","volume":"368","author":"F Fusi","year":"2003","unstructured":"Fusi F, Saponara S, Frosini M, Gorelli B, Sgaragli G (2003) L-type Ca2+ channels activation and contraction elicited by myricetin on vascular smooth muscles. Naunyn Schmiedeberg\u2019s Arch Pharmacol 368:470\u2013478","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"1266_CR9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00280-007-0488-6","volume":"61","author":"F Fusi","year":"2008","unstructured":"Fusi F, Ferrara A, Zalatnai A, Molnar J, Sgaragli G, Saponara S (2008) Vascular activity of two silicon compounds, Alis-409 and Alis-421, novel multidrug-resistance reverting agents in cancer cells. Cancer Chemother Pharmacol 61:443\u2013451","journal-title":"Cancer Chemother Pharmacol"},{"key":"1266_CR10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.2042-7158.1994.tb03789.x","volume":"46","author":"AM Gurney","year":"1994","unstructured":"Gurney AM (1994) Mechanisms of drug-induced vasodilation. J Pharm Pharmacol 46:242\u2013251","journal-title":"J Pharm Pharmacol"},{"key":"1266_CR11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00656997","volume":"391","author":"OP Hamill","year":"1981","unstructured":"Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patchclamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85\u2013100","journal-title":"Pflugers Arch"},{"key":"1266_CR12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00417-004-1104-7","volume":"244","author":"S Hoffmann","year":"2006","unstructured":"Hoffmann S, Balthasar S, Friedrichs U, Ehren M, Ryan SJ, Wiedemann P (2006) Inhibitory effects of verapamil isomers on the proliferation of choroidal endothelial cells. Graefe\u2019s Arch Clin Exp Ophthalmol 244:376\u2013381","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"1266_CR13","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"JJ Irwin","year":"2012","unstructured":"Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: a free tool to discover chemistry for biology. J Chem Inf Model 52:1757\u20131768","journal-title":"J Chem Inf Model"},{"key":"1266_CR14","first-page":"234","volume":"29","author":"B Lilly","year":"2014","unstructured":"Lilly B (2014) We have contact: endothelial cell-smooth muscle cell interactions. Physiology (Bethesda) 29:234\u2013241","journal-title":"Physiology (Bethesda)"},{"key":"1266_CR15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00041433-200310000-00007","volume":"14","author":"TD Littlewood","year":"2003","unstructured":"Littlewood TD, Bennett MR (2003) Apoptotic cell death in atherosclerosis. Curr Opin Lipidol 14:469\u2013475","journal-title":"Curr Opin Lipidol"},{"key":"1266_CR16","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/jm8012745","volume":"52","author":"C Martelli","year":"2009","unstructured":"Martelli C, Alderighi D, Coronnello M, Dei S, Frosini M, Le Bozec B, Manetti D, Neri A, Romanelli MN, Salerno M, Scapecchi S, Mini E, Sgaragli G, Teodori E (2009) N,N-bis(cyclohexanol)amine aryl esters: a new class of highly potent transporter-dependent multidrug resistance inhibitors. J Med Chem 52:807\u2013817","journal-title":"J Med Chem"},{"key":"1266_CR17","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1021\/jm9016174","volume":"53","author":"C Martelli","year":"2010","unstructured":"Martelli C, Coronnello M, Dei S, Manetti D, Orlandi F, Scapecchi S, Romanelli MN, Salerno M, Mini E, Teodori E (2010) Structure-activity relationships studies in a series of N,N-bis(alkanol)amine aryl esters as P-glycoprotein (P-gp) dependent multidrug resistance (MDR) inhibitors. J Med Chem 53:1755\u20131762","journal-title":"J Med Chem"},{"key":"1266_CR18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bmcl.2010.11.059","volume":"21","author":"C Martelli","year":"2011","unstructured":"Martelli C, Dei S, Lambert C, Manetti D, Orlandi F, Romanelli MN, Scapecchi S, Salerno M, Teodori E (2011) Inhibition of P-glycoprotein-mediated multidrug resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: further restriction of molecular flexibility maintains high potency and efficacy. Bioorg Med Chem Lett 21:106\u2013109","journal-title":"Bioorg Med Chem Lett"},{"key":"1266_CR19","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791","journal-title":"J Comput Chem"},{"key":"1266_CR20","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/sj.bjp.0703959","volume":"132","author":"T Murata","year":"2001","unstructured":"Murata T, Yamawaki H, Hori M, Sato K, Ozaki H, Karaki H (2001) Chronic vascular toxicity of doxorubicin in an organ-cultured artery. Br J Pharmacol 132:1365\u20131373","journal-title":"Br J Pharmacol"},{"key":"1266_CR21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bmc.2012.11.019","volume":"21","author":"F Orlandi","year":"2013","unstructured":"Orlandi F, Coronnello M, Bellucci C, Dei S, Guandalini L, Manetti D, Martelli C, Romanelli MN, Scapecchi S, Salerno M, Menif H, Bello I, Mini E, Teodori E (2013) New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR). Bioorg Med Chem 21:456\u2013465","journal-title":"Bioorg Med Chem"},{"key":"1266_CR22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/mol.108.050492","volume":"75","author":"MM Pires","year":"2009","unstructured":"Pires MM, Emmert D, Hrycyna CA, Chmielewski J (2009) Inhibition of P-glycoprotein-mediated paclitaxel resistance by reversibly linked quinine homodimers. Mol Pharmacol 75:92\u2013100","journal-title":"Mol Pharmacol"},{"key":"1266_CR23","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/01.CIR.99.15.2019","volume":"99","author":"MJ Pollman","year":"1999","unstructured":"Pollman MJ, Naumovski L, Gibbons GH (1999) Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells. Circulation 99:2019\u20132026","journal-title":"Circulation"},{"key":"1266_CR24","doi-asserted-by":"crossref","unstructured":"Raaphorst RM, Windhorst AD, Elsinga PH, Colabufo NA, Lammertsma AA, Luurtsema G (2015) Radiopharmaceuticals for assessing ABC transporters at the blood-brain barrier. Clin Pharmacol Ther 97:362\u201371","DOI":"10.1002\/cpt.73"},{"key":"1266_CR25","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/ci00020a039","volume":"34","author":"J Sadowski","year":"1994","unstructured":"Sadowski J, Gasteiger J, Klebe G (1994) Comparison of automatic three-dimensional model builders using 639 X-ray structures. J Chem Inf Comput Sci 34:1000\u20131008","journal-title":"J Chem Inf Comput Sci"},{"key":"1266_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.taap.2012.04.036","volume":"262","author":"JK Salabei","year":"2012","unstructured":"Salabei JK, Balakumaran A, Frey JC, Boor PJ, Treinen-Moslen M, Conklin DJ (2012) Verapamil stereoisomers induce antiproliferative effects in vascular smooth muscle cells via autophagy. Toxicol Appl Pharmacol 262:265\u2013272","journal-title":"Toxicol Appl Pharmacol"},{"key":"1266_CR27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000330452","volume":"88","author":"S Saponara","year":"2011","unstructured":"Saponara S, Gorelli B, Tzankova V, Martelli C, Teodori E, Sgaragli G, Fusi F (2011) The novel potent multidrug resistance inhibitors N,N-bis(cyclohexanol)amine aryl esters are devoid of vascular effects. Pharmacology 88:137\u2013141","journal-title":"Pharmacology"},{"key":"1266_CR28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/bph.13369","volume":"173","author":"S Saponara","year":"2016","unstructured":"Saponara S, Durante M, Spiga O, Mugnai P, Sgaragli G, Huong TT, Khanh PN, Son NT, Cuong NM, Fusi F (2016) Murrayafoline A modulation of rat vascular myocytes Cav1.2 channel: functional, electrophysiological and molecular docking analysis. Br J Pharmacol 173:292\u2013304","journal-title":"Br J Pharmacol"},{"key":"1266_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.013","volume":"149","author":"R Silva","year":"2015","unstructured":"Silva R, Vilas-Boas V, Carmo H, Dinis-Oliveira RJ, Carvalho F, de Lourdes BM, Remi\u00e3o F (2015) Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy. Pharmacol Ther 149:1\u2013123","journal-title":"Pharmacol Ther"},{"key":"1266_CR30","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1021\/cr4006236","volume":"114","author":"G Szak\u00e1cs","year":"2014","unstructured":"Szak\u00e1cs G, Hall MD, Gottesman MM, Boumendjel A, Kachadourian R, Day BJ, Baubichon-Cortay H, Di Pietro A (2014) Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance. Chem Rev 114:5753\u20135774","journal-title":"Chem Rev"},{"key":"1266_CR31","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1021\/jm050542x","volume":"48","author":"E Teodori","year":"2005","unstructured":"Teodori E, Dei S, Garnier-Suillerot A, Gualtieri F, Manetti D, Martelli C, Romanelli MN, Scapecchi S, Sudwan P, Salerno M (2005) Exploratory chemistry toward the identification of a new class of multidrug resistance reverters inspired by pervilleine and verapamil models. J Med Chem 48:7426\u20137436","journal-title":"J Med Chem"},{"key":"1266_CR32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreding. J Comput Chem 31:455\u2013461","journal-title":"J Comput Chem"},{"key":"1266_CR33","first-page":"203","volume":"223","author":"T Tsuruo","year":"1986","unstructured":"Tsuruo T (1986) Acquired vs innate multidrug resistance and the effect of calcium channel blockers. Prog Clin Biol Res 223:203\u2013216","journal-title":"Prog Clin Biol Res"},{"key":"1266_CR34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jlcr.2993","volume":"56","author":"T Wanek","year":"2013","unstructured":"Wanek T, Mairinger S, Langer O (2013) Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood\u2013brain barrier. J Label Comp Radiopharm 56:68\u201377","journal-title":"J Label Comp Radiopharm"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-016-1266-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-016-1266-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-016-1266-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T23:35:01Z","timestamp":1718667301000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-016-1266-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,28]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["1266"],"URL":"https:\/\/doi.org\/10.1007\/s00210-016-1266-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,28]]}}}